16414351Ujiki MB, Milam B, Ding XZ, Roginsky AB, Salabat MR, Talamonti MS, Bell RH, Gu W, Silverman RB, Adrian TEBiochemical and biophysical research communicationsCell Cycle; Cell Proliferation; Depsipeptides; Pancreatic NeoplasmsAntineoplastic Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; HumansA novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest. Biochem Biophys Res Commun. 2006 Feb 24; 340(4):1224-8.Biochem Biophys Res Commun2006-01-05T00:00:002006A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000970Chemicals & Drugs40723510.435461Antineoplastic AgentsD002453Physiology1905020.841822Cell CycleD004305Concepts & Ideas52019580.724084Dose-Response Relationship, DrugD010190Disorders1596450.652334Pancreatic NeoplasmsAuthorship 287366Authorship 287371D006801Living Beings2262862810.130052Humans0.2827140.07067842authors10.259has subject areaD049109Physiology43515710.639735Cell ProliferationD047630Chemicals & Drugs20290.977481DepsipeptidesD002460Anatomy54024660.697085Cell LineD002470Physiology3269660.814107Cell SurvivalSurgeryUniversity of ChicagoMarkTalamontiMark Talamonti41.78927490000000-87.601250000000002316Talamonti, MarkClinical ProfessorMichaelUjikiMichael Ujiki41.78927490000000-87.601250000000002446Ujiki, MichaelClinical Assistant Professortrue1Clinical ProfessorClinical Professortrue1Clinical Assistant ProfessorClinical Assistant Professor